checkAd

    EQS-News  121  0 Kommentare Affluent Medical achieves the clinical objective of the Dry pilot study in the first two patients with the Artus artificial urinary sphincter

    Für Sie zusammengefasst
    • Affluent Medical achieves clinical objective of Dry pilot study
    • Successful activation of Artus device in first two patients
    • Addressing substantial medical need with innovative medical device

    EQS-News: Affluent Medical SA / Key word(s): Miscellaneous
    Affluent Medical achieves the clinical objective of the Dry pilot study in the first two patients with the Artus artificial urinary sphincter

    18.06.2024 / 17:45 CET/CEST
    The issuer is solely responsible for the content of this announcement.


    PRESS RELEASE

    Affluent Medical achieves the clinical objective of the Dry pilot study in the first two patients with the Artus artificial urinary sphincter

    • Second successful implantation of the innovative Artus medical device in Krakow, Poland
    • Successful activation of the Artus device in the first two patients six weeks after surgery
    • Artus, an artificial sphincter adapted to the treatment of incontinence in both men and women, addresses a substantial medical need with 400 million patients affected worldwide

    Aix-en-Provence, June 18, 2024 – 5:45 PM CEST – Affluent Medical (ISIN: FR0013333077 – Ticker: AFME), a French clinical-phase MedTech company specializing in the international development and industrialization of innovative medical prostheses, is announcing the successful activation of its Artus medical device for the treatment of urinary incontinence in the first two patients as part of the European pilot study, “Dry”.

    After the successful implantation of the Artus device in an initial patient in the Czech Republic, as reported last March, the device has been successfully implanted in a 70-year-old man suffering from urinary incontinence in Poland by the urologist Professor Piotr Chlosta, President of the Department of Urology of the Faculty of Medicine of Jagiellonian University in Krakow and Head of the Clinical Department of Urology and Oncology at the University Hospital of Krakow.

    This second minimally invasive procedure confirmed the ease with which the Artus device can be prepared and implanted, with a surgery time of 45 minutes.

    The two Artus devices were successfully activated six weeks after each surgery. The safety criteria were met and both patients expressed no discomfort using the device. A performance assessment will be carried out in the pivotal phase, the aim being to reduce urinary leakage three months after the activation of the device.

    Seite 1 von 3



    EQS Group AG
    0 Follower
    Autor folgen

    Verfasst von EQS Group AG
    EQS-News Affluent Medical achieves the clinical objective of the Dry pilot study in the first two patients with the Artus artificial urinary sphincter EQS-News: Affluent Medical SA / Key word(s): Miscellaneous Affluent Medical achieves the clinical objective of the Dry pilot study in the first two patients with the Artus artificial urinary sphincter 18.06.2024 / 17:45 CET/CEST The issuer is …

    Schreibe Deinen Kommentar

    Disclaimer